Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy.
Moreno DF, Pereira A, Tovar N, Cibeira MT, Magnano L, Rozman M, López-Guerra M, Colomer D, Martín-Antonio B, Jiménez-Segura R, Isola I, Rodríguez-Lobato LG, Oliver-Caldés A, Mena MP, Rosiñol L, Bladé J, Fernández de Larrea C.
Moreno DF, et al. Among authors: cibeira mt.
Cancers (Basel). 2021 Apr 23;13(9):2055. doi: 10.3390/cancers13092055.
Cancers (Basel). 2021.
PMID: 33922804
Free PMC article.